revyve™ Antimicrobial Wound Gel is a premium hydrogel that provides scientifically-proven efficacy for wound healing in an easy-to-use thermo-reversible gel, and is affordably priced for all settings of care. Why use any other hydrogel?
The Triple Threat Approach To Wound Care
revyve™ Antimicrobial Wound Gel is indicated for the use on:
- Partial and full thickness wounds
- Leg ulcers
- Large surface area wounds
- Pressure ulcers
- Surgical incisions
- 1st and 2nd degree burns
- Diabetic foot ulcers
revyve™ Antimicrobial Wound Gel Main Components
- coactiv+™
(EDTA and Citric Acid) - PHMB
(Preservative) - Non-ionic
pluronic surfactant
Biofilm impaired healing - the largest unresolved problem in wound care.
Studies have reported a prevalence of biofilms in over 78% of chronic wounds. Biofilms are a glue-like substance excreted by bacteria and/or fungi to attach to surfaces. They protect and allow bacteria to survive and thrive in hostile environments. Biofilms make bacteria up to 1,000 times more resistant to antibiotics and antimicrobials and are one of the main contributors to antibiotic resistance.
revyve™ Antimicrobial Wound Gel is effective against:
GRAM-NEGATIVE BACTERIA
Escherichia coli
Acinetobacter baumannii
Klebsiella pneumoniae
Pseudomonas aeruginosa
GRAM-POSITIVE BACTERIA
Staphylococcus aureus
Methicillin Resistant Staphylococcus aureus
Enterococcus faecalis
Streptococcus pyogenes
Cutibacterium acnes
FUNGI
Candida albicans
About Kane Biotech
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (67 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. Kane®, StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactiv+®, DermaKB™, DermaKB Biofilm™ and revyve™ are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol “KNE” and on the OTCQB Venture Market under the symbol “KNBIF”.